Scenario-based analysis of stage distribution and stage-specific survival among Māori diagnosed with lung cancer in Aotearoa New Zealand
Year: 2026
Type: article
Study design: Observational Study
Abstract: INTRODUCTION: Lung cancer survival in Aotearoa New Zealand differs between Māori and European populations. This study used scenario-based standardisation to compare survival when Māori estimates were standardised to the European stage distribution, stage-specific survival or both. The scenarios aimed to assess which of these differences was associated with the larger change in estimated survival. METHODS: National cancer registry data were used to identify all primary lung cancers for Māori and European populations diagnosed between 2015 and 2024, with mortality follow-up to December 2025. Survival was modelled using sex-specific Cox regression, including age at diagnosis and diagnosis year, ethnicity, Surveillance, Epidemiology, and End Results (SEER) summary stage, and an ethnicity-by-stage interaction. Survival probabilities at 1, 3 and 5 years were estimated. Scenarios were constructed for Māori in which stage distribution, stage-specific survival or both were standardised to those of Europeans. RESULTS: Five-year survival was lower for Māori than for Europeans among males (11.3%, 95% confidence interval [CI] 9.4-13.7 vs 16.8%, 95% CI 15.2-18.7) and females (17.1%, 95% CI 15.0-19.5 vs 24.2%, 95% CI 22.5-26.2). Standardising stage distribution increased estimated 5-year survival to 13.5% (95% CI 11.4-16.2) for Māori males and 20.2% (95% CI 17.9-22.9) for Māori females. Standardising stage-specific survival produced larger increases, to 17.2% (95% CI 15.4-19.3) and 23.4% (95% CI 21.5-25.6), respectively. Estimates were highest when both were standardised, at 19.5% (95% CI 17.7-21.7) and 26.6% (95% CI 24.7-28.8). CONCLUSIONS: Differences in both stage distribution and stage-specific survival were associated with lung cancer survival inequities. Standardising stage-specific survival produced a larger change than standardising stage distribution alone.
Source: New Zealand Medical Journal
DOI: 10.26635/6965.7656
Institutions: Health New Zealand, University of Otago
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7234255314
